If you are wondering whether AstraZeneca shares are offering fair value at current levels, this breakdown will help you connect the recent share price with what the underlying business might justify.

How AstraZeneca’s recent performance may look to long term holders AstraZeneca (LSE:AZN) shares have moved mixed recently, with a 2.7% decline over the past day, a small gain over the past week, a 1.7 ...

The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the ...

FTSE 100 Live 30 January: Gold retreats ahead of Fed choice, AstraZeneca strikes China deal - ...

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.